Parnassus Value Select ETF Rating $25.72 -0.05 (-0.19%) As of 08/15/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Parnassus Value Select ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PRVS Aggregate RatingModerate Buy 2.72Holdings in PRVS have an aggregate rating of Moderate Buy based on 491 analyst ratings issued in the past year covering 24 companies (92.3% of the portfolio).PRVS Aggregate Price Target$25.72High Prediction$25.72Average Prediction$25.72Low Prediction$25.72Holdings in PRVS have an aggregate price target of $25.72 and a range of $25.72 to $25.72 covering 24 companies (92.3% of the portfolio).PRVS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Parnassus Value Select ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 PRVS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.03%SPGIS&P Global$550.38-1.1%4.7886 of 5 stars3.00$611.69 11.1%15Positive News4.85%MSFTMicrosoft$515.71-0.9%4.9071 of 5 stars2.94$612.54 18.8%32Trending NewsAnalyst Forecast4.79%CBRECBRE Group$157.77-0.7%4.1429 of 5 stars2.78$158.00 0.1%9Positive NewsInsider Trade4.59%DEDeere & Company$489.02+0.0%3.9556 of 5 stars2.50$524.00 7.2%20Trending NewsEarnings ReportAnalyst Forecast4.44%AZNAstraZeneca$79.22+0.1%2.9295 of 5 stars2.80$86.00 8.6%5Positive NewsAnalyst Revision4.41%VVisa$342.28-0.6%4.7567 of 5 stars2.86$380.84 11.3%28Positive News4.39%VZVerizon Communications$44.38+0.3%4.7063 of 5 stars2.60$47.35 6.7%20Positive News4.27%JPMJPMorgan Chase & Co.$291.22+0.3%4.7496 of 5 stars2.52$288.68 -0.9%23Positive News4.12%SCHWCharles Schwab$96.51+0.4%4.7857 of 5 stars2.67$99.60 3.2%21Trending NewsAnalyst ForecastAnalyst Revision4.10%GOOGLAlphabet$203.06-0.4%4.0396 of 5 stars2.86$211.53 4.2%43Trending NewsAnalyst Revision4.09%BEPCBrookfield Renewable$33.72+0.8%3.3094 of 5 stars2.67$33.67 -0.1%3Positive News3.84%TSMTaiwan Semiconductor Manufacturing$241.20+1.0%2.826 of 5 stars3.00$258.33 7.1%4Positive News3.73%UNPUnion Pacific$219.86-0.4%4.8006 of 5 stars2.56$258.21 17.4%27Positive NewsShort Interest ↑Analyst Revision3.72%AMZNAmazon.com$231.04+0.0%4.7127 of 5 stars3.02$262.87 13.8%49Trending News3.47%BACBank of America$47.92+2.1%4.8092 of 5 stars2.77$50.13 4.6%223.41%LINLinde$477.61-0.5%3.488 of 5 stars3.00$519.63 8.8%11News CoveragePositive News3.41%TMOThermo Fisher Scientific$490.79+0.4%4.9581 of 5 stars2.71$593.00 20.8%21Positive NewsAnalyst Revision3.35%AMATApplied Materials$163.93+1.3%4.8361 of 5 stars2.57$194.84 18.9%28Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision3.35%CMICummins$401.46+0.5%4.7262 of 5 stars2.43$370.83 -7.6%14Positive NewsInsider Trade3.30%BIOBio-Rad Laboratories$284.60-0.4%4.5622 of 5 stars2.75$333.50 17.2%4Positive News3.28%ABNBAirbnb$125.66+0.4%4.1814 of 5 stars2.31$142.72 13.6%39Positive News3.12%SYYSysco$79.22-0.4%4.6219 of 5 stars2.71$85.69 8.2%14Positive NewsInsider Trade2.72%CMCSAComcast$33.49+0.1%4.9766 of 5 stars2.41$40.73 21.6%27Positive News2.56%WTWWillis Towers Watson Public$329.76-0.2%3.9105 of 5 stars2.67$362.92 10.1%12News CoverageAnalyst ForecastShort Interest ↑Analyst Revision This page (NYSEARCA:PRVS) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Parnassus Value Select ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Parnassus Value Select ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access